Follow
Adnan Nagrial
Adnan Nagrial
University of Sydney
Verified email at health.nsw.gov.au
Title
Cited by
Cited by
Year
Genomic analyses identify molecular subtypes of pancreatic cancer
P Bailey, DK Chang, K Nones, AL Johns, AM Patch, MC Gingras, ...
Nature 531 (7592), 47-52, 2016
31092016
Whole genomes redefine the mutational landscape of pancreatic cancer
N Waddell, M Pajic, AM Patch, DK Chang, KS Kassahn, P Bailey, ...
Nature 518 (7540), 495-501, 2015
25952015
Pancreatic cancer genomes reveal aberrations in axon guidance pathway genes
AV Biankin, N Waddell, KS Kassahn, MC Gingras, LB Muthuswamy, ...
Nature 491 (7424), 399-405, 2012
21712012
Pan-cancer analysis of whole genomes
Nature 578 (7793), 82-93, 2020
1641*2020
Prognostic and Clinicopathologic Associations of Oncogenic BRAF in Metastatic Melanoma
GV Long, AM Menzies, AM Nagrial, LE Haydu, AL Hamilton, GJ Mann, ...
Journal of Clinical Oncology 29 (10), 1239-1246, 2011
12572011
Whole-genome landscape of pancreatic neuroendocrine tumours
A Scarpa, DK Chang, K Nones, V Corbo, AM Patch, P Bailey, RT Lawlor, ...
Nature 543 (7643), 65-71, 2017
8272017
The prognostic and predictive value of serum CA19. 9 in pancreatic cancer
JL Humphris, DK Chang, AL Johns, CJ Scarlett, M Pajic, MD Jones, ...
Annals of oncology 23 (7), 1713-1722, 2012
3362012
Efficacy and safety of pembrolizumab for the treatment of advanced biliary cancer: results from the KEYNOTE‐158 and KEYNOTE‐028 studies
SA Piha‐Paul, DY Oh, M Ueno, D Malka, HC Chung, A Nagrial, RK Kelley, ...
International journal of cancer 147 (8), 2190-2198, 2020
3352020
Precision medicine for advanced pancreas cancer: the individualized molecular pancreatic cancer therapy (IMPaCT) trial
LA Chantrill, AM Nagrial, C Watson, AL Johns, M Martyn-Smith, ...
Clinical cancer research 21 (9), 2029-2037, 2015
2402015
Transient tissue priming via ROCK inhibition uncouples pancreatic cancer progression, sensitivity to chemotherapy, and metastasis
C Vennin, VT Chin, SC Warren, MC Lucas, D Herrmann, A Magenau, ...
Science translational medicine 9 (384), eaai8504, 2017
2362017
Hypermutation in pancreatic cancer
JL Humphris, AM Patch, K Nones, PJ Bailey, AL Johns, S McKay, ...
Gastroenterology 152 (1), 68-74. e2, 2017
2102017
Histomolecular phenotypes and outcome in adenocarcinoma of the ampulla of vater
DK Chang, NB Jamieson, AL Johns, CJ Scarlett, M Pajic, A Chou, ...
Journal of clinical oncology 31 (10), 1348-1356, 2013
1822013
Evaluation of combination nivolumab and ipilimumab immunotherapy in patients with advanced biliary tract cancers: subgroup analysis of a phase 2 nonrandomized clinical trial
O Klein, D Kee, A Nagrial, B Markman, C Underhill, M Michael, L Jackett, ...
JAMA oncology 6 (9), 1405-1409, 2020
1762020
Circulating tumor DNA as a potential marker of adjuvant chemotherapy benefit following surgery for localized pancreatic cancer
B Lee, L Lipton, J Cohen, J Tie, AA Javed, L Li, D Goldstein, M Burge, ...
Annals of Oncology 30 (9), 1472-1478, 2019
1582019
Chemotherapy and radiotherapy for advanced pancreatic cancer
V Chin, A Nagrial, K Sjoquist, CA O'Connor, L Chantrill, AV Biankin, ...
Cochrane Database of Systematic Reviews, 2018
1422018
Clinical and molecular characterization of HER2amplified-pancreatic cancer
A Chou, N Waddell, MJ Cowley, AJ Gill, DK Chang, AM Patch, K Nones, ...
Genome medicine 5, 1-11, 2013
1382013
First-in-human phase 1 study of the anti-TIGIT antibody vibostolimab as monotherapy or with pembrolizumab for advanced solid tumors, including non-small-cell lung cancer☆
J Niu, C Maurice-Dror, DH Lee, DW Kim, A Nagrial, M Voskoboynik, ...
Annals of Oncology 33 (2), 169-180, 2022
1362022
Immunotherapy of ipilimumab and nivolumab in patients with advanced neuroendocrine tumors: a subgroup analysis of the CA209-538 clinical trial for rare cancers
O Klein, D Kee, B Markman, M Michael, C Underhill, MS Carlino, L Jackett, ...
Clinical Cancer Research 26 (17), 4454-4459, 2020
1322020
Pembrolizumab (pembro) for advanced biliary adenocarcinoma: Results from the KEYNOTE-028 (KN028) and KEYNOTE-158 (KN158) basket studies.
YJ Bang, M Ueno, D Malka, HC Chung, A Nagrial, RK Kelley, ...
Journal of Clinical Oncology 37 (15_suppl), 4079-4079, 2019
1322019
Tailored first-line and second-line CDK4-targeting treatment combinations in mouse models of pancreatic cancer
A Chou, D Froio, AM Nagrial, A Parkin, KJ Murphy, VT Chin, D Wohl, ...
Gut 67 (12), 2142-2155, 2018
1202018
The system can't perform the operation now. Try again later.
Articles 1–20